Dehydrogenase/reductase SDR family member 2 silencing sensitizes an oxaliplatin-resistant cell line to oxaliplatin by inhibiting excision repair cross-complementing group 1 protein expression

Oxaliplatin (Oxa)-based chemotherapy is widely used as the first-line treatment for colorectal cancer (CRC). However, Oxa-resistance is common for many postoperative CRC patients. To explore drug resistance in CRC, an Oxa-resistant cell line, HCT116/Oxa, was established from parental HCT116 cells. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ji-Min, Jiang, Guan-Min, Zhao, Liang, Yang, Fang, Yuan, Wei-Qi, Wang, Hao, Luo, Yi-Qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775812/
https://www.ncbi.nlm.nih.gov/pubmed/31436301
http://dx.doi.org/10.3892/or.2019.7291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775812/
https://www.ncbi.nlm.nih.gov/pubmed/31436301
http://dx.doi.org/10.3892/or.2019.7291

Ejemplares similares